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Background: To control the spread of methicillin-resistant Staphylococcus aureus (MRSA) in hospitals, infection
control measures such as hand hygiene practices were introduced into the teaching hospitals in Shanghai, China,
in 2008. Currently, there is limited information characterizing the latest hospital-acquired S. aureus infections in this
area. Therefore, we sought to determine the prevalence, molecular characteristics, and genotype-phenotype
correlation of hospital-acquired S. aureus infections in Huashan Hospital, one of the largest teaching hospitals
in Shanghai.
Results: Among 608 hospital-acquired S. aureus clinical isolates obtained from January to December of 2011 in
Huashan Hospital, 68.1% were MRSA. The predominant MRSA clones were ST239-SCCmecIII and ST5-SCCmecII.
ST239 was mainly recovered from respiratory specimens and sterile body fluids, ST5 was associated with respiratory
specimens and blood, and ST1 was most prevalent in urine samples. In this study, 31 dispersed sequence types
(STs) of methicillin-susceptible S. aureus (MSSA) were identified, most of which caused skin/soft tissue infection and
bacteremia. The frequencies of pvl-, muPA-, and qacA/B-positive isolates were 1.6, 9.9, and 11.8% respectively. MuPA
was more frequently identified in ST1 and ST5, and qacA/B was more prevalent in ST239 and ST5. Most of the pvl-
positive isolates were MSSA, whereas the majority of muPA- and qacA/B-positive isolates were MRSA. ST239 and ST5
had higher resistance rates to multiple antibiotics. In Huashan Hospital, the infection rate in the intensive care unit
(ICU) was 3.9 per 1000 hospitalized days, but only 1.2 per 1000 hospitalized days in the other wards. Each ward
harbored its own dominant STs. Pulsed-field gel electrophoresis showed diversity within the same epidemic S.
aureus clones originating from the same wards.
Conclusion: There is still a high prevalence of MRSA infections in the teaching hospital in Shanghai. There were
also differences in the major infection types caused by MRSA and MSSA, and hospital-acquired S. aureus infections
in the ICU of Huashan Hospital pose a greater threat to patient safety than in other wards. The high proportion of
multiple antibiotic and chlorhexidine-based antiseptic-resistant clones in this hospital underscores the need for
more effective infection control measures to help curtail dissemination of MRSA to hospitalized patients.
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S. aureus is a globally important human pathogen, causing
a variety of diseases such as pneumonia, skin and soft
tissue infections, blood-stream infections, osteomyelitis,
and endocarditis, as well as toxin-mediated syndromes
like toxic shock syndrome and food poisoning [1,2]. Since
the onset of the pandemic waves of MRSA over the past
decades, it has become the most common cause of both* Correspondence: ruth_limin124@yahoo.com
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reproduction in any medium, provided the orhospital- and community-acquired infection worldwide
[3]. According to epidemiological data in 2005, the mean
prevalence of MRSA across China was more than 50%,
and in Shanghai, the rate was over 80% [4]. To control the
spread of MRSA in hospitals, measures such as universal
hand hygiene practices have been introduced into Shanghai
teaching hospitals. However, as yet there are no programs
to screen for asymptomatic MRSA carriers in Chinese
hospitals. A re-evaluation of the level of MRSA infection in
Shanghai teaching hospitals is required to evaluate the
effect of the current infection control measures.his is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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wide belong to five pandemic MRSA lineages: CC5,
CC8, CC22, CC30, and CC45 [5-9]. Some virulence
genes show strong associations with specific molecular
types; for instance, the sea, sek, and seq genes were iden-
tified in all ST239 strains. In contrast, ST5 was strongly
associated with the tst, seg, sei, sem, sen, and seo gene
profiles [10]. Conversely, the expression of core genome-
encoded virulence genes varies between molecular types
of S. aureus [11], indicating that discrete sequence types
(STs) may correlate with specific infection types. For
example, the MRSA clone USA300 mainly causes skin
and soft tissue infections (SSTIs) in the United States
[12]. To the best of our knowledge, there is limited
information characterizing the latest hospital-acquired S.
aureus infections in hospitals in Shanghai, China. There-
fore, we sought to determine the prevalence, molecular
characteristics, and genotype-phenotype correlation of
hospital-acquired S. aureus infections at one of the
largest teaching hospitals in Shanghai.
Results
The population composition and types of infection
caused by S. aureus
The clinical and demographic characteristics of the inpa-
tients with S. aureus infection are listed in Table 1. Among
the 608 hospital-acquired S. aureus isolates obtained
between January and December 2011, there were 414
(68.1%) MRSA isolates and 194 (31.9%) MSSA isolates.
From the clinical medical records, respiratory infection
was the most frequently determined infection type caused
by S. aureus; 67.4% (410/608) of the isolates were from the
respiratory tract, and most of the S. aureus isolates reco-
vered from respiratory infection were MRSA (78.3%).
Conversely, only 36.1% (31/86) of isolates recovered from
skin/soft tissue infections were methicillin resistant.
The STs of current MRSA and MSSA epidemic strains in
Huashan Hospital
All S. aureus isolates were typed by multilocus sequence
typing (MLST). There were 31 distinct STs identifiedTable 1 Population composition and types of infection cause
Sex No. (%) Age No. (%) So
Male 401 (66.0%) 14–24 43 (7.1%) Re
Female 207 (34.0%) 25–34 56 (9.2%) Sk
35–44 63 (10.4%) Ot
45–54 81(13.3%) Blo
55–64 92 (15.1%) Ur
65–74 96 (15.8%)
75–84 72 (11.8%)
≥85 105 (17.3%)within the 608 isolates (Figure 1), among which the most
frequently represented were ST239 (33.2%, 202/608),
ST5 (30.3%, 184/608), ST1 (5.3%, 32/608), ST7 (4.4%,
27/608), and ST188 (3.5%, 21/608). MSSA isolates were
associated with all 31 STs, with ST7 (13.4%, 26/194) and
ST188 (10.3%, 20/194) being the two dominant types for
MSSA isolates. MRSA ST239 was mainly recovered from
respiratory specimens (38.5%) and sterile body fluids
(50.0%), but was only found at a frequency of 8.1% and
3.7% in skin/soft tissue and blood infections, respec-
tively. ST5 isolates were most often present in respiratory
specimens (34.6%) and blood (44.4%), but were isolated at
a frequency of only 15.6% and 16.3% from sterile body
fluids and skin/soft tissue samples, respectively. ST1
strains were mainly found in urine samples (28.6%). Most
other dispersed STs were associated with MSSA strains
causing skin/soft tissue infection (51.2%) and bacteremia
(37.0%) (Figure 2).
SCCmec types of 414 MRSA isolates from Huashan Hospital
SCCmec types I–V were detected in this study. Of the
414 MRSA strains, 0.2% (1/414), 38.9% (161/414), 46.6%
(193/414), 12.6% (52/414), and 1.0% (4/414) were
SCCmec types I–V, respectively. Three MRSA strains
carrying SCCmec were defined as non-typeable (NT)
(Table 2). The predominant STs amongst the MRSA
isolates were ST239-SCCmecIII (43.7%, 181/414) and
ST5-SCCmecII (35.0%, 145/414). The other two most
common MRSA STs were ST1-SCCmecIV (6.5%, 27/414)
and ST59-SCCmecIV(2.2%, 9/414). ST239-SCCmecI, ST239-
SCCmecII, ST5-SCCmecIII, and ST5-SCCmecIV strains
were also detected in Huashan Hospital.
Antimicrobial susceptibility profiles
We analyzed 608 S. aureus isolates with 31 different STs
for antimicrobial resistance (Table 3). All the isolates
were susceptible to vancomycin, teicoplanin, and linezo-
lid. Resistance to penicillin (97.4%) was observed most
frequently, and ST239 and ST5 strains had significantly
higher multiple antibiotic-resistance profiles when com-
pared with other STs. ST5 strains were more susceptibled by S. aureus
urce No. (%) MRSA/MSSA
spiratory 410 (67.4%) 321/89 (78.3%/21.7%)
in/soft tissue 86 (14.1%) 31/55 (36.0%/64.0%)
her sterile body fluids 64 (10.5%) 37/27 (57.8%/42.2%)
od 27 (4.4%) 12/15 (44.4%/55.6%)
ine 21 (3.6%) 13/8 (61.9%/38.1%)
Figure 1 Molecular types of the 608 non-duplicated S. aureus isolates from Huashan Hospital in 2011.
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methoprim (P < 0.001) but more resistant to fosfomycin
(P < 0.001) than ST239. ST1 isolates were susceptible to
most antibiotics except penicillin (96.9%), levofloxacin
(59.4%), cefoxitin (87.5%), and cefazolin (78.1%), while
ST7 strains were susceptible to most of the antibiotics
except penicillin (100.0%), levofloxacin (96.3%), and
erythromycin (55.6%). ST188 strains were only resistantFigure 2 Prevalence of the epidemic S. aureus STs among
different clinical specimens.to penicillin (90.5%). In this study, 15 isolates of animal
infection-associated ST398 were identified, all of which
were susceptible to cefoxitin. These isolates were only
resistant to penicillin (80.0%) and erythromycin (66.7%).
Association of genotypes, and detection of the pvl, muPA,
and qacA/B genes
Ten (1.6%) isolates were pvl-positive, and they displayed
six different STs (Table 4). Four (26.7%, 4/15) pvl-posi-
tive isolates were ST398, two (20.0%, 2/10) isolates
belonged to ST88, and one isolate each belonged to
ST338, ST22, ST59, and ST7. With the exception of one
ST59 and one ST7 MRSA isolate, all of the pvl-positive
isolates were MSSA. Sixty (9.9%) isolates were muPA-
positive, and they displayed 11 different STs. Twenty-
one (65.6%, 21/32) muPA-positive isolates were ST1,
twenty (10.9%, 20/184) isolates belonged to ST5, and
seven (3.5%, 7/202) isolates belonged to ST239. There
were two isolates each of ST7, ST59, ST630, and ST398,
and one isolate belonged to each of the STs ST680,
ST188, and ST1036. Most of the muPA-positive isolates
were MRSA (85.0%, 51/60). Seventy-two (11.8%) isolates
were qacA/B-positive and displayed eight different STs.
Thirty-eight (18.8%, 38/202) and twenty-eight (15.2%,
28/184) qacA/B-positive isolates were ST239 and ST5,
Table 2 SCCmec types of 414 MRSA isolates arranged by
STs
MLST MRSA SCCmec type
No. I II III IV V NT
ST239 198 1 (0.5%) 16 (8.1%) 181 (91.4%) 0 0 0
ST5 168 0 145 (86.3%) 10 (6.0%) 13 (7.7%) 0 0
ST1 28 0 0 1 (3.6%) 27 (96.4%) 0 0
ST59 10 0 0 1 (10.0%) 9 (90.0%) 0 0
ST1821 2* 0 0 0 0 2 0
ST181 1 0 0 0 1 0 0
ST630 1 0 0 0 0 1 0
ST680 1 0 0 0 0 0 1
ST7 1 0 0 0 0 1 0
ST88 1 0 0 0 1 0 0
ST9 1 0 0 0 0 0 1
ST965 1 0 0 0 1 0 0
ST188 1 0 0 0 0 0 1
*STs with less than 10 isolates were not calculated in the percentage of
SCCmec type.
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qacA/B-positive isolates was 90.3% (65/72).
The prevalence of different genotypes in different wards
To investigate whether there were epidemic S. aureus
clones that could survive and spread in different wards,
we next analyzed the ICU, one of the largest compre-
hensive surgical wards, and two of the largest medical
wards. As shown in Figure 3, different STs were detected
in different wards, and each ward had its own dominant
STs. ST239 was a robust sequence type, and was
prevalent in the ICU and surgical ward, while ST5 was
prevalent in both medical wards and surgical wards. In
medical wards, ST5, ST1, and ST680 were the predo-
minant three clones, whilst isolates belonging to other
STs were recovered at a rate of three isolates per month.
Pulsed-field gel electrophoresis (PFGE) was used to
compare the genetic variation of the dominant STs
recovered from different wards. Figure 3 (E and F)
showed that the restriction profiles of the same epidemic
S. aureus clones originating from the same wards were
not identical. The major DNA restriction pattern was
named type A, and isolates with closely (1–3 fragment
differences) or possibly related (4–6 fragment differ-
ences) restriction patterns were considered subtypes of
A, and were designated type A1, type A2, and so on.
Those with more than six fragment differences were
regarded as type B [13]. PFGE type A1 was the major
pattern of the prevalent clone ST239 in the ICU, but the
PFGE patterns of prevalent clone ST5 in medical ward 1
were more dispersed.Discussion
Surveillance data from China suggested that S. aureus
infections account for a substantial burden of disease
[6]. Most of the individuals infected with hospital-onset
S. aureus in this study were men (66.0%), which was
consistent with findings from a previous study [14].
Unlike the incidence of community-onset S. aureus,
which is highest in the younger age groups [15,16],
hospital-acquired S. aureus usually causes infections in
immunocompromised populations aged 55 years or
above. In our study, more than 60% of S. aureus isolates
were isolated from this group, suggesting that the bio-
logy and pathogenesis of community-acquired S. aureus
differs from that of hospital-acquired S. aureus. Since
the 1980s, MRSA has become a serious clinical problem
worldwide. In Shanghai, the mean prevalence of MRSA
was over 80% in 2005 [4]. Therefore, it is very important
to restrict the spread of MRSA in both hospitals and
community settings. To control MRSA transmission,
measures such as universal hand hygiene practices were
introduced into Shanghai teaching hospitals in 2008.
This study demonstrated that MRSA healthcare-onset
infections were still extremely frequent (68.1%) in the
central teaching hospital in Shanghai in 2011, despite
the application of infection control measures.
Previous data demonstrated that the epidemic MRSA
clones in Asian countries belong to CC8 (ST239) and
CC5 (ST5). The ST239 MRSA clone was first discovered
in Brazil and has since become widely disseminated in
various hospitals [17]. ST239 has been the dominant
clone in most of the cities in China since 2005 [18]. In
our study, ST239-SCCmecIII still presented as the most
frequent MRSA ST, with ST5-SCCmecII identified as the
second most common epidemic MRSA clone. This clone
was initially described as the main clone in the United
States [19] and Japan [20], and was subsequently
detected in China [18]. ST239-SCCmecI, ST239-SCC
mecII, ST5-SCCmecIII, and ST5-SCCmecIV were also
detected in this study. The occurrence of different
SCCmec types in the same MRSA clonal lineage led to
the hypothesis that these elements were acquired inde-
pendently at several times through horizontal gene
transfer [21]. Multidrug-resistant clones ST239 and ST5
mainly caused respiratory-related infection in our study.
This could explain why 78.3% of isolates recovered from
patients with respiratory infections were MRSA. ST239
strains were isolated at a frequency of only 8.1 and 3.7%
from skin/soft tissue and blood, respectively. ST5 strains
were isolated from 16.3% of skin/soft tissue samples in
this study, which was lower than in the study of Yu et al.
[22], who demonstrated that ST239 strains accounted
for only 18.9% of bloodstream infections. We found that
ST5 isolates were more susceptible to rifampicin and
sulfamethoxazole plus trimethoprim, but more resistant
Table 3 Antimicrobial susceptibility profiles of 608 S. aureus isolates arranged by STs
MLST No. P LEV CN FOX CZ E DA RD SXT FOS TEC VA LZD
% Resistance
ST239 202 100.0 98.5 98.0 98.0 98.0 85.6 67.3 72.8 23.8 25.3 0.0 0.0 0.0
ST5 184 98.9 91.9 82.1 91.3 91.3 94.0 73.4 3.3 1.1 75.0 0.0 0.0 0.0
ST1 32 96.9 59.4 3.1 87.5 78.1 9.4 3.1 3.1 0.0 18.8 0.0 0.0 0.0
ST7 27 100.0 96.3 18.5 3.7 0.0 55.6 25.9 0.0 0.0 0.0 0.0 0.0 0.0
ST188 21 90.5 4.8 4.8 4.8 4.8 33.3 9.5 0.0 4.8 0.0 0.0 0.0 0.0
ST680 18 100.0 88.9 5.6 5.6 0.0 83.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0
ST59 17 82.4 11.8 0.0 52.9 41.2 82.4 76.5 11.8 5.9 0.0 0.0 0.0 0.0
ST15 17 100.0 0.0 0.0 0.0 0.0 70.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0
ST6 16 100.0 0.0 0.0 0.0 0.0 12.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0
ST398 15 80.0 13.3 20.0 0.0 0.0 66.7 40.0 0.0 0.0 0.0 0.0 0.0 0.0
ST630 12 91.7 50.0 0.0 8.3 0.0 58.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0
ST88 10 90.0 0.0 30.0 10.0 10.0 60.0 30.0 0.0 10.0 0.0 0.0 0.0 0.0
ST20 5a 5 1 0 0 0 0 0 0 0 0 0 0 0
ST1821 4 4 0 0 2 0 1 0 0 0 0 0 0 0
ST965 3 3 0 1 1 0 3 1 0 0 0 0 0 0
ST573 3 3 1 0 0 0 3 1 0 0 1 0 0 0
ST181 2 2 0 1 1 0 0 0 0 0 0 0 0 0
ST22 2 2 0 0 0 0 2 0 0 0 0 0 0 0
ST25 2 2 0 0 0 0 1 0 0 0 0 0 0 0
ST30 2 2 0 0 0 0 0 0 0 0 0 0 0 0
ST946 2 2 0 0 0 0 1 1 0 0 0 0 0 0
ST338 1 1 0 0 0 0 1 1 0 0 0 0 0 0
ST359 1 1 0 0 0 0 1 0 0 0 0 0 0 0
ST707 1 0 0 0 0 0 1 1 0 0 0 0 0 0
ST223 1 1 1 0 0 0 0 0 0 0 0 0 0 0
ST121 1 1 0 1 0 0 1 1 0 0 0 0 0 0
ST1649 1 1 0 0 0 0 1 0 0 0 0 0 0 0
ST2149 1 0 0 0 0 0 0 0 0 0 0 0 0 0
ST221 1 1 0 0 0 0 0 0 0 0 0 0 0 0
ST9 1 1 0 1 1 1 1 1 0 0 0 0 0 0
ST97 1 0 0 0 0 0 0 0 0 0 0 0 0 0
Total 608 97.4 72.9 60.4 68.1 66.0 75.2 51.0 25.7 8.7 32.2 0.0 0.0 0.0
a STs with less than 10 isolates were not calculated in the percentage of antibiotic resistance.
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appropriate drug selection based on different MRSA
types may reduce the reservoir of drug-resistant bacteria.
Different STs were associated with different virulence
profiles, and the expression of core genome-encoded
virulence genes differed between discrete molecular
types of S. aureus [10,11]. This could explain in part
why different clonal types may be associated with
specific infection types. Li et al. [23] recently identified a
novel surface-anchored protein, SasX, as a crucial factor
in promoting nasal colonization, immune evasion, and
virulence, and as a probable main driving force of theAsian ST239 MRSA epidemic. Therefore, possible mecha-
nisms for the ST5 MRSA epidemic in this region should
be assessed in future studies.
The other two common MRSA STs were ST1-SCC
mecIV and ST59-SCCmecIV, which closely resemble
those of the well-known epidemic CA-MRSA clones.
ST1 bears the same ST as MW2 (USA400, SCCmecIV),
which was the first CA-MRSA strain reported in the
United States [19]. The major Asian CA-MRSA strain
was ST59-SCCmecIV [24,25], and was reported to be
prevalent in skin and soft tissue infections. The molecu-
lar characteristics of the MSSA isolates were genetically
Table 4 Association of genotypes, pvl, muPA, and qacA/B
genes
STs % (No./total) MRSA/MSSA
qacA/B(+)
ST239 18.8% (38/202) 100.0% (38/38)
ST5 15.2% (28/184) 96.4% (27/28)
ST6 6.3% (1/16) 0/1






ST398 26.7% (4/15) 0/4
ST88 20.0% (2/10) 0/2
ST59 5.9% (1/17) 1/0




ST1 65.6% (21/32) 100% (21/21)
ST630 16.7% (2/12) 0/2
ST398 13.3% (2/15) 0/2
ST59 11.8% (2/17) 2/0
ST5 10.9% (20/184) 100.0% (20/20)
ST7 7.4% (2/27) 0/2
ST680 5.6% (1/18) 1/0
ST188 4.8% (1/21) 0/1
ST239 3.5% (7/202) 7/0
ST1036 1/2 0/1
ST121 1/1 0/1
a STs with less than 10 isolates were not calculated in the percentage of genes
present or MRSA/MSSA.
Li et al. BMC Microbiology 2013, 13:153 Page 6 of 10
http://www.biomedcentral.com/1471-2180/13/153diverse in this study, and most MSSA strains caused
skin/soft tissue infection and bacteremia. ST7 and
ST188 were the two dominant types. ST188 was a
double-locus variant of ST1, which was the predicted
founder of the community-acquired ST1 type. Sixteen
animal-associated clone types, including 15 ST398 and
one ST9, were also found in the present study. Human
infections caused by ST398 isolates have been reported
in many countries [26,27]. All of the ST398 isolates in
this study were MSSA, and four carried the gene coding
for PVL. PVL is suggested to be an important virulence
factor in CA-MRSA isolates, and there is a strong
epidemiological association between PVL genes and
successful CA-MRSA lineages, especially in skin/soft
tissue disease [28,29]. Our data suggest that the externalcommunity acted as a significant reservoir of MRSA/
MSSA strains related to the skin/soft tissue disease that
occurred in hospitals. For this reason, traditional infec-
tion control strategies aimed solely at the prevention of
MRSA/MSSA transmission in hospitals may be ineffec-
tive. New approaches, including public health measures
that focus on the community as a source of MRSA/
MSSA, are needed to control this epidemic.
In 2008, infection control measures were introduced
into Shanghai teaching hospitals to help control the spread
of MRSA. Surface-active antiseptics such as chlorhexidine
were strongly recommended as decolonization agents in
our hospital, especially in the ICU and surgical wards.
Emerging resistance to the use of these kinds of antiseptics
was a particular concern. The qacA/B genes were found in
11.8% of the S. aureus clinical isolates in our study. Most
of the qacA/B-positive clones were MRSA ST239 and
ST5, which are very prevalent in the ICU and surgical
ward, suggesting that the over-use of antiseptic agents has
led to the emergence of MRSA strains with decreased
antiseptic susceptibility. Mupirocin treatment was another
comprehensive strategy in reducing S. aureus colonization
and infection in the hospital [30]. In our study, 9.9% of
isolates were muPA-positive, and the majority of muPA -
positive isolates were MRSA types ST1 and ST5. Mupi-
rocin resistance in S. aureus, especially in MRSA, has been
reported in many studies [31,32]. McNeil et al. showed
that 11% of S. aureus isolates from children with recurrent
skin and soft tissue infections carried muPA. Thus, detec-
tion of mupirocin resistance in S. aureus, particularly in
MRSA, is necessary to maintain the usefulness of this
agent for the treatment of S. aureus infections and for
infection control.
The rates of hospital-acquired S. aureus infection varied
between the different departments of Huashan Hospital.
During the 12 months of this study, 4198 patients were
hospitalized in the ICU for an aggregate of 33,584 days,
sustaining 131 hospital-acquired S. aureus infections. The
rate of hospital-acquired S. aureus infection was 3.9 per
1000 ICU-days. The other 31,147 patients were hospital-
ized in different wards for an aggregate of 386,029 days,
sustaining 477 hospital-acquired S. aureus infections. The
overall rate of hospital-acquired S. aureus infection in the
other wards was 1.2 per 1000 hospitalized days. Therefore,
hospital-acquired S. aureus infections in the ICU of the
Shanghai teaching hospital pose a greater threat to patient
safety than those in the other wards.
Finally, we found each ward had its own dominant
STs. This is possibly because different STs exhibit dis-
tinct virulence profiles, and each ST is related to specific
infection types. In this study, we observed that the
strains with the same MLST types did not necessarily
have the same PFGE profiles. PFGE can detect genetic
variation that accumulates relatively rapidly, and even
Figure 3 (See legend on next page.)
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Figure 3 Dynamic changes of the epidemic S. aureus clones in different wards in 2011. A-D: Dynamic changes of the top five most
prevalent S. aureus clones in the ICU (A), the largest comprehensive surgical ward (B), and two large medical wards (C and D). E-F: PFGE profiles
of the dominant STs recovered from the same wards. The PFGE profiles of ST239 recovered from the ICU (E). The PFGE profiles of ST5 recovered
from medical ward 1 (F). The major DNA restriction pattern was named type A, and isolates with closely (1–3 fragment differences) or possibly
related (4–6 fragment differences) restriction patterns were considered subtypes of A, and were designated type A1, type A2, and so on. Those
with more than six fragment differences were regarded as type B.
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resulting in creation or loss of a restriction site) can
produce a three-fragment difference in the PFGE gel
banding pattern [13,33]. Insertions, deletions, or the pres-
ence of plasmids can alter the PFGE pattern without ne-
cessarily changing the DNA sequence of the seven
housekeeping genes used for MLST, creating diversity in
PFGE patterns in the face of homogeneity among MLST
patterns obtained for the same isolates. From this point of
view, PFGE is more informative than MLST as it involves
random screening of the entire genome, whereas MLST
analysis is limited to nucleotides within the targeted genes.
Conclusion
Overall, the present data indicate that there is still a high
prevalence of MRSA infections in the teaching hospital in
Shanghai, China. The current infection control measures
have failed to reduce rates of MRSA infections to accep-
table levels for decolonization. The high proportion of
multidrug-resistant and chlorhexidine-based antiseptic-
resistant clones ST239 and ST5 in the ICU and surgical
wards supports the need for more effective infection con-
trol measures to curtail the colonization and dissemi-
nation of MRSA to hospitalized patients.
Methods
Bacterial isolates
From January to December of 2011, 608 sequential S. aur-
eus isolates, which represent all the non-duplicate strains
isolated during the study period, were collected from inpa-
tients of a comprehensive teaching hospital in Shanghai,
China (Huashan Hospital, affiliated with Fudan University).
This hospital is located in the center of Shanghai and is
one of the largest (1300 beds) teaching hospitals, handling
about 8000 admissions per day. All of the inpatients in our
study acquired S. aureus infection after hospital admission.
These isolates were derived from diverse clinical speci-
mens, including the respiratory tract (nasopharyngeal swab
and bronchial alveolar lavage fluid), skin and soft tissue
(cutaneous abscess and wound secretion), sterile body
fluids (pleural cavity fluid, cerebrospinal fluid, and articular
cavity fluid), blood, and urine (Table 1). S. aureus isolates
were confirmed by classic microbiological methods: Gram
stain and catalase and coagulase activity on rabbit plasma.
S. aureus strains were further identified by biochemical
characterization using the Api-Staph test (bioMérieux,Lyon, France). All strains were stored at −70°C until use.
Research carried out on patients with S. aureus infections
in accordance with the protocols approved by the ethics
committees of Huashan Hospital, Fudan University,
Shanghai, People’s Republic of China (Reference number:
2012 M-0072).
Antimicrobial susceptibility testing
The standard disk diffusion method was used to test the
antibiotic susceptibility of all isolates, and results were
interpreted in accordance with the Clinical and Laboratory
Standards Institute (CLSI) guidelines (CLSI, 2008). Anti-
biogram classifications were made on the basis of suscepti-
bility to 13 antimicrobials: penicillin(P), levofloxacin (LEV),
gentamycin (CN), cefoxitin (FOX), cefazolin (CZ), eryth-
romycin (E), clindamycin (DA), rifampicin (RD), sulfa-
methoxazole + trimethoprim (SXT), fosfomycin (FOS),
teicoplanin (TEC), vancomycin (VA), and linezolid (LZD).
MLST
Isolates were screened using a previously described
method [34] to detect the following seven housekeeping
genes: carbamate kinase (arcC), shikimate dehydrogen-
ase (aroE), glycerol kinase (glp), guanylate kinase (gmk),
phosphate acetyltransferase (pta), triosephosphate isom-
erase (tpi), and acetyl coenzyme A acetyltransferase
(yqiL). The sequences of the PCR products were
compared with the existing sequences available from the
MLST website (http://www.mlst.net) for S. aureus [35],
and the allelic number was determined for each sequence.
PFGE
PFGE was used to compare the genetic diversity of the
dominant STs recovered from the same ward. Briefly,
SmaI-digested DNA embedded in agarose plugs was
subjected to PFGE analysis at 14°C in a CHEF-MAPPER
system (Bio-Rad) at 6 V/cm, in 0.5 × Tris-borate-EDTA
buffer, for two stages: first stage, initial pulse, 5 s; final
pulse, 15 s for 10 h; second stage, initial pulse, 15 s, final
pulse, 60 s for 10 h; angle 120°.
SCCmec typing
Typing of the SCCmec cassette was performed by PCR
as described by Kondo et al. [36] and was based on a set
of multiplex PCRs (M-PCRs). In this system, M-PCRs 1
and 2 were used for SCCmec type assignment; M-PCR 3
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subtyping, and M-PCRs 5 and 6 were used to identify
the integrated copies of transposons (Tn554 or Tn554)
and plasmids (pUB110 or pT181).
pvl-, muPA-, and qacA/B-specific PCRs
Isolates were tested for the presence of the Panton-
Valentine leukocidin gene (pvl), mupirocin-resistance
protein-encoding gene (muPA), and chlorhexidine-based
antiseptic resistance loci (qacA/B) by PCR using the fol-
lowing primers: pvl-F 5′-ATCATTAGGTAAAATGTC
TGGACATGATCCA-3′, pvl-R 5′-GCATCAACTGTAT
TGGATAGCAAAAGC-3′ (PCR product size: 433 bp);
muPA–F 5′-CATTGGAAGATGAAATGCATACC-3′,
muPA–R 5′-CGCAGTCATTATCTTCACTGAG-3′ (PCR
product size: 443 bp); qacA/B-F 5′-CTATGGCAATAGG
AGATATGGTGT-3′, qacA/B-R 5′-CCACTACAGATTC
TTCAGCTACATG-3′ (PCR product size: 416 bp). The
amplification was carried out on a GeneAmp 9700
thermal cycler (Applied Biosystems, NY, USA) under the
following conditions: an initial 5 min denaturation at
94°C, followed by 35 cycles of 30 s at 94°C, 30 s at 55°C,
and 30 s at 72°C, with a final extension at 72°C for 7 min.
In each PCR, a positive control and a negative control
(distilled water) were included. The PCR fragments were
visualized by agarose gel electrophoresis and ethidium
bromide staining.
Statistical analysis
Statistical analyses were performed using Stata software
(version 10.1/SE, Stata Corp, College Station, TX, USA).
We used the χ2 and Fisher’s exact tests, as appropriate
for analysis of categorical data. Statistical significance
was set at P ≤0.05.
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